Dose tailoring of dabigatran etexilate: obvious or excessive?
about
Perioperative management of patients on direct oral anticoagulants.Evaluation of the chromogenic anti-factor IIa assay to assess dabigatran exposure in geriatric patients with atrial fibrillation in an outpatient setting.Real-Life Peak and Trough Dabigatran Plasma Measurements over Time in Hospitalized Geriatric Patients with Atrial Fibrillation.Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians.Clinical implications of genetic variation in carboxylesterase drug metabolism.Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin.Interindividual variability in dabigatran and rivaroxaban exposure: contribution ofABCB1genetic polymorphisms and interaction with clarithromycin
P2860
Q33692054-10AA0AC4-2B19-4FAE-96F8-8E1B1E6910B9Q36875879-B7F00F87-6C06-4EB7-8989-94C88FB839B2Q47210396-1D62669D-F6E3-4E48-A8E0-E1DEB9A4783CQ48199813-21432E68-9A6D-4D78-87CF-1DD6378C37DBQ49628042-953FC674-A41A-4339-AC05-FAE3FE325E8EQ53140080-F4625FAA-526E-4CD4-BBF7-45ED24EA8D30Q57314038-0582567D-BDFF-477F-B874-4CE5A333F056
P2860
Dose tailoring of dabigatran etexilate: obvious or excessive?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Dose tailoring of dabigatran etexilate: obvious or excessive?
@en
type
label
Dose tailoring of dabigatran etexilate: obvious or excessive?
@en
prefLabel
Dose tailoring of dabigatran etexilate: obvious or excessive?
@en
P2860
P1476
Dose tailoring of dabigatran etexilate: obvious or excessive?
@en
P2093
Jean-Michel Dogné
P2860
P304
P356
10.1517/14740338.2015.1049995
P407
P577
2015-05-21T00:00:00Z